Advertisement

Label-Free Kinetic Analysis of an Antibody–Antigen Interaction Using Biolayer Interferometry

Part of the Methods in Molecular Biology book series (MIMB, volume 1278)

Abstract

Biolayer Interferometry (BLI) is a powerful technique that enables direct measurement of biomolecular interactions in real time without the need for labeled reagents. Here we describe the analysis of a high-affinity binding interaction between a monoclonal antibody and purified antigen using BLI. A simple Dip-and-Read™ format in which biosensors are dipped into microplate wells containing purified or complex samples provides a highly parallel, user-friendly technique to study molecular interactions. A rapid rise in publications citing the use of BLI technology in a wide range of applications, from biopharmaceutical discovery to infectious diseases monitoring, suggests broad utility of this technology in the life sciences.

Key words

Label-free Antibody Antigen PSA Biolayer interferometry Affinity constant Kinetic analysis Ligand Analyte Biosensor Association Dissociation 

References

  1. 1.
    Rich RL, Myszka DG (2010) Grading the commercial optical biosensor literature - Class of 2008: ‘The Mighty Binders’. J Mol Recognit 23:1–64CrossRefPubMedGoogle Scholar
  2. 2.
    Rich RL, Myszka DG (2007) Higher-throughput, label-free, real-time molecular interaction analysis. Anal Biochem 361:1–6CrossRefPubMedGoogle Scholar
  3. 3.
    Cooper MA (2006) Optical biosensors: where next and how soon? Drug Discov Today 11:1061–1067CrossRefPubMedGoogle Scholar
  4. 4.
    Concepcion J et al (2009) Label-free detection of biomolecular interactions using BioLayer Interferometry for kinetic characterization. Comb Chem High Throughput Screen 12:791–800CrossRefPubMedGoogle Scholar
  5. 5.
    Elwing H (1998) Protein absorption and ellipsometry in biomaterial research. Biomaterials 19:397–406CrossRefPubMedGoogle Scholar
  6. 6.
    Markey F (2009) Macromolecular interactions. In: Cooper MA (ed) Label-free biosensors. Cambridge University Press, Cambridge, pp 143–158CrossRefGoogle Scholar
  7. 7.
    Myszka DG (1999) Improving biosensor analysis. J Mol Recognit 12:279–284CrossRefPubMedGoogle Scholar
  8. 8.
    Pall ForteBio Application Note 8: optimizing protein-protein and protein-small molecule kinetics assays. (2012). http://www.fortebio.com/literature.html
  9. 9.
    Karlsson R, Falt A (1997) Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J Immunol Methods 200:121–133CrossRefPubMedGoogle Scholar
  10. 10.
    Pall ForteBio Technical Note 8: regeneration strategies for amine reactive biosensors on the octet system. (2007). http://www.fortebio.com/literature.html
  11. 11.
    Pall ForteBio Technical Note 14: regeneration strategies for streptavidin biosensors on the octet platform. (2009). http://www.fortebio.com/literature.html
  12. 12.
    Katsamba P et al (2006) Kinetic analysis of a high-affinity antibody/antigen interaction performed by multiple Biacore users. Anal Biochem 352:208–211CrossRefPubMedGoogle Scholar
  13. 13.
    More information may be found at www.fortebio.com
  14. 14.
    Pall ForteBio Technical Note 28: biotinylation of protein for immobilization onto streptavidin biosensors. (2011). http://www.fortebio.com/literature.html

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.ForteBio Inc. - A Division of Pall Life SciencesMenlo ParkUSA

Personalised recommendations